Top Markets
Coin of the day
Valeo Pharma Inc. Valeo Pharma Inc.

Valeo Pharma Inc.

VPHIF
शेयरों में रैंक #41805
Valeo Pharma Inc. is a Canadian specialty pharmaceutical firm dedicated to... Valeo Pharma Inc. is a Canadian specialty pharmaceutical firm dedicated to sourcing, licensing, and selling a variety of medicinal products, with a primary emphasis on respiratory, specialized, and hospital-grade generic drugs. Its extensive product lineup features prominent asthma medications like Enerzair Breezhaler (a triple-combination LABA/LAMA/ICS) and Atectura Breezhaler (a dual-combination LABA/ICS). The company also offers Redesca, crucial for preventing and treating deep vein thrombosis and pulmonary embolism. For neurological conditions, Valeo markets Onstryv, an add-on treatment for Idiopathic Parkinson's Disease in patients on stable Levodopa, and Benztropine, an anticholinergic for PD. Pain management is addressed with M-Eslon, an extended-release morphine sulfate, while Yondelis targets soft tissue sarcoma. Beyond these, the portfolio includes Hesperco, an immune-supporting bioflavonoid antioxidant; Ametop, a skin anesthetic used before venous procedures; Ethacrynate Sodium, a loop diuretic for high blood pressure and swelling; and Amikacin, an injectable antibiotic. Founded in 2003, Valeo Pharma Inc. is headquartered in Kirkland, Canada.
शेयर मूल्य
$0.0001
अंतिम समन्वयन: 2026-08-11
मार्केट कैप
$9.87K
बदलाव (1 दिन)
0.00%
बदलाव (1 वर्ष)
-99.79%
देश
CA
व्यापार Valeo Pharma Inc. (VPHIF)

श्रेणी

Valeo Pharma Inc. (VPHIF) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $0.00 (2026-08-01 को)

दिन का सबसे निम्न समापन मूल्य: $0.85 (2020-09-01 को)
Valeo Pharma Inc. के स्टॉक मूल्य का इतिहास 2020 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) 0.00%
2025 -99.79%
2024 -64.24%
2023 -71.62%
2022 -18.52%
2021 -36.53%
2020 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$171.67 -
DE
$166.06 27.73%
DE
$36.01 21.71%
JP
$228.90 41.12%
CH
$21.45 14.41%
IN